NVCR - NovoCure Ltd
IEX Last Trade
19.44
-0.310 -1.595%
Share volume: 1,141,770
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$19.75
-0.31
-1.57%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-27 | 2023-02-23 | 2023-05-04 | 2023-07-27 | 2023-10-26 | 2024-02-22 | 2024-05-02 | 2024-07-25 | |
| Assets | |||||||||
| Total Assets | 1.174 B | 1.192 B | 1.174 B | 1.159 B | 1.146 B | 1.146 B | 1.121 B | 1.212 B | |
| Current Assets | 1.102 B | 1.112 B | 1.089 B | 1.065 B | 1.048 B | 1.034 B | 1.003 B | 1.093 B | |
| Inventories | 26.792 M | 29.376 M | 31.723 M | 33.023 M | 36.806 M | 38.152 M | 42.391 M | 40.442 M | |
| Other Current Assets | 17.478 M | 25.959 M | 23.730 M | 20.148 M | 23.163 M | 22.677 M | 21.479 M | 32.858 M | |
| Short Term Investments | 17.478 M | 25.959 M | 23.730 M | 20.148 M | 23.163 M | 22.677 M | 21.479 M | 32.858 M | |
| Total Receivables | 87.552 M | 86.261 M | 74.830 M | 70.988 M | 65.133 M | 61.221 M | 65.091 M | 64.703 M | |
| Current Cash | 970.320 M | 969.425 M | 958.035 M | 940.815 M | 921.248 M | 910.616 M | 870.147 M | 951.186 M | |
| Total Non-current Assets | 71.842 M | 80.119 M | 85.346 M | 93.525 M | 98.351 M | 111.720 M | 118.721 M | 119.334 M | |
| Property Plant Equipment | 41.730 M | 45.362 M | 48.670 M | 52.675 M | 56.921 M | 62.863 M | 70.828 M | 78.196 M | |
| Other Assets | 10.707 M | 11.161 M | 11.147 M | 14.572 M | 12.416 M | 14.022 M | 14.899 M | 12.062 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.174 B | 1.192 B | 1.174 B | 1.159 B | 1.146 B | 1.146 B | 1.121 B | 1.212 B | |
| Total liabilities | 728.814 M | 750.478 M | 742.194 M | 743.332 M | 752.649 M | 783.633 M | 762.074 M | 850.420 M | |
| Total current liabilities | 141.076 M | 158.777 M | 148.775 M | 150.087 M | 157.161 M | 179.115 M | 160.230 M | 169.178 M | |
| Accounts Payable | 77.026 M | 85.197 M | 81.469 M | 82.536 M | 79.668 M | 94.391 M | 84.316 M | 90.171 M | |
| Other liabilities | 8.234 M | 7.358 M | 7.122 M | 5.766 M | 5.448 M | 8.276 M | 6.584 M | 6.041 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 564.677 M | 565.581 M | 566.324 M | 567.150 M | 567.986 M | 568.822 M | 569.652 M | 653.470 M | |
| Other liabilities | 8.234 M | 7.358 M | 7.122 M | 5.766 M | 5.448 M | 8.276 M | 6.584 M | 6.041 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 445.401 M | 441.170 M | 432.146 M | 415.683 M | 393.704 M | 362.496 M | 359.355 M | 361.750 M | |
| Common stock | 104.885 M | 104.943 M | 105.667 M | 106.289 M | 106.773 M | 106.836 M | 107.266 M | 107.700 M | |
| Retained earnings | -741.157 M | -778.460 M | -831.521 M | -888.939 M | -938.424 M | -985.503 M | -1.024 B | -1.058 B |